Global Cervical Dysplasia market to touch US$ 848 Mn by 2026 at a CAGR of 6.8%
Noida, Uttar Pradesh, India, April 6 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Cervical dysplasia is a precancerous condition caused due to the abnormal growth of the cells on the surface of the cervix. Cancer screening is the only diagnostic procedure that can identify cervical dysplasia. The cervical cancer screening identifies dysplastic lesions for consequent excision to avert invasive disease. There is a clinical counterbalance regarding disease surveillance among women, after treatment with some Canadian provinces solely performing colposcopy and others utilizing Human Papilloma Virus (HPV) testing and cervical cytology. Loop Electrosurgical Excision Procedure (LEEP) is used to treat the pre-invasive HPV-mediated disease, with patients following up for 12 months after disease excision. The Global Cervical Dysplasia Market is estimated to see modest growth, pegged at a CAGR of around 6.8% throughout the forecast period 2020-2026.
GET SAMPLE PAGES @ https://reportocean.com/industry-verticals/sample-request?report_id=mai52961
Backed by the high incidence of cervical cancer in women aged 60 years and above, elderly women are not included in the screening programs for cervical cancer prevention. In Sweden, around 30% of cervical cancer cases occur in women over 60, and the mortality rate is nearly 70% in this age group, as per the National Center for Biotechnology Information (NCBI). Moreover, cervical cancer in women aged 65 and above is usually discovered at advanced stages and poor prognoses. The opportunistic Pap smear screening has significantly reduced squamous cell cancer incidence in groups most regularly screened by about 70%. The 2015 Swedish cervical screening regulations are under execution, and from 2017 HPV based screening for women of 30–64 years of age is recommended.
Moreover, in elderly women, there is a lack of knowledge regarding the prevalence of HPV and HPV-related dysplasia. As per the NCBI survey, a significant proportion of elderly women have a persistent cervical HPV infection and a high CIN (cervical intraepithelial neoplasia) prevalence diagnosed by histology. The cytology has exceedingly low sensitivity in this age group. Though, the DNA-based HPV tests are more sensitive, as compared to cytology, in detecting pre-malignant lesions on the cervix. In post-menopausal women, the transformation zone where precursor lesions develop is higher in the cervical canal due to hormonal changes. Therefore, it is not reachable for proper examination and sampling. Thus, colposcopy and cytology are considered less appropriate methods for detecting cervical dysplasia in this age group.
Segmentation Overview of the Global Cervical Dysplasia Market
The cervical dysplasia market is segmented based on the diagnosis type and end user. These major market segments are further categorized into various sub-segments to study the market in detail.
By Diagnosis Type Outlook (Diagnostic Tests (HPV Test, Pap Smear Test, Biopsy Test), Diagnostic Devices)
By End User Outlook (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
Key Players Insights
Qiagen NV; Quest Diagnostics; Abbott Laboratories; Hologic, Inc.; Karl Kaps GmbH & Co. KG; DYSIS Medical Ltd.; CooperSurgical Inc.; Micromedic Technologies Ltd.; OncoHealth Corporation, Inc.; BD; Roche, among others, are some significant players included in the research study of the global cervical dysplasia market.
Feel Free To Ask Question Before Purchasing The Report @ https://reportocean.com/industry-verticals/sample-request?report_id=mai52961
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at firstname.lastname@example.org.